Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal of Neurosurgery. Case Lessons|May 25, 2026
The "en bloc" shift: ipsilateral and contralateral abducens nerve palsy following microvascular decompression for trigeminal neuralgia caused by vertebrobasilar dolichoectasia. Illustrative casesShoko Ito, Kenzo Kosugi, Hiroaki Fukumoto, et al.
Journal of the Neurological Sciences|September 27, 2023
Switching between anti-calcitonin gene-related peptide monoclonal antibodies: A comparison of monthly and quarterly dosingKeiko Ihara, Seiya Ohtani, Narumi Watanabe, et al.
Frontiers in Neurology|May 19, 2023
Migraine triggers in Asian countries: a narrative reviewChisato Iba, Seiya Ohtani, Mi Ji Lee, et al.
Internal Medicine (Tokyo, Japan)|January 5, 2025
Efficacy and Safety of Switching Between Anti-CGRP Monoclonal Antibodies: A Detailed Monthly and Long-term Follow-up Study and Literature ReviewKota Oshima, Keiko Ihara, Narumi Watanabe, et al.
Radiology Case Reports|May 22, 2026
Clear cell carcinoma arising from abdominal wall endometriosis: A case report with imaging findings and pathologic correlationMidori Nakajima, Shinji Kato, Shunsuke Shibata, et al.
BMC Neurology|January 3, 2025
Vertebral artery dissection in a patient with migraine treated with calcitonin gene-related peptide monoclonal antibody: a case report and FAERS database analysisDaiki Tokuyasu, Shungo Imai, Shih-Pin Chen, et al.
BMC Neurology|November 14, 2023
Real-world evidence of fremanezumab for treating migraine in Japan: a retrospective studySeiya Ohtani, Narumi Watanabe, Keiko Ihara, et al.
Internal Medicine (Tokyo, Japan)|August 13, 2025
Effect of Galcanezumab on PHQ-9 and GAD-7 in Patients with Migraine: A Real-world Study in JapanKota Oshima, Yuna Hattori, Keiko Ihara, et al.
The Journal of Headache and Pain|March 8, 2023
Predicting response to CGRP-monoclonal antibodies in patients with migraine in Japan: a single-centre retrospective observational studyKeiko Ihara, Seiya Ohtani, Narumi Watanabe, et al.
Expert Opinion on Drug Metabolism & Toxicology|November 5, 2023
Metabolic and toxicological considerations regarding CGRP mAbs and CGRP antagonists to treat migraine in COVID-19 patients: a narrative reviewTsubasa Takizawa, Keiko Ihara, Shunsuke Uno, et al.
Pageof 3